Alpha 2.0
Login Register
» Authors » Laura M Yates

Laura M Yates

Explore the profile of Laura M Yates including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 250
Followers 0
Related Specialties
Pharmacology
Neurology
Genetics
Top 10 Co-Authors
Ursula Winterfeld
Eugene P van Puijenbroek
Rebecca L Bromley
David J Lewis
Yvonne Geissbuhler
Lorraine Eley
Alan Moore
Judith A Goodship
Yrea R J van Rijt-Weetink
Guillaume Favre
Published In
Drug Saf
Epilepsia
Neurology
Am J Med Genet A
Hum Mol Genet
Affiliations
Soon will be listed here.
Recent Articles
1.
Delphi Method Consensus on Statistical Analysis and Reporting Recommendations for Single-Arm Pregnancy Medication Safety Studies Investigating Pregnancy, Birth and Neonatal Health Outcomes: A Contribution from IMI-ConcePTION
Richardson J, Moore A, Stellfeld M, Geissbuhler Y, Winterfeld U, Favre G, et al.
Drug Saf . 2025 Feb; PMID: 39907983
Background And Objective: Standardised procedures for performing and reporting safety monitoring studies investigating medications use in pregnancy may help improve data quality and the speed of data generation. The objective...
2.
'No causative variants found': an unusual presentation of PAX2-related disorder not detected on rapid whole exome sequencing testing
Wells P, Basu A, Yates L
BMJ Case Rep . 2025 Jan; 18(1). PMID: 39842896
Paired box 2 ()-related disorder, also known as renal coloboma syndrome, is a variably penetrant autosomal dominant condition, associated with renal and ophthalmological abnormalities. We report a child with -related...
3.
The use of parent-completed questionnaires to investigate developmental outcomes in large populations of children exposed to antiseizure medications in pregnancy
Bluett-Duncan M, Bullen P, Campbell E, Clayton-Smith J, Craig J, Garcia-Finana M, et al.
Epilepsia . 2024 May; 65(7):2017-2029. PMID: 38776170
Objective: This study was undertaken to assess the utility of the Ages and Stages Questionnaire-3rd Edition (ASQ-3) and the Vineland Adaptive Behavior Scales-2nd Edition (VABS-II) as neurodevelopmental screening tools for...
4.
Validation of a Novel Method to Assess the Clinical Quality of Information in Pregnancy-Related Pharmacovigilance Case Reports: A ConcePTION Project
van Rijt-Weetink Y, Egberts T, van Hunsel F, Lewis D, Yates L, Winterfeld U, et al.
Drug Saf . 2024 Jan; 47(3):261-270. PMID: 38183608
Background: To assess the causal relationship between a medicinal product and a reported event, relevant information needs to be present. Information elements for assessing cases of exposure to medicinal products...
5.
Improving Data Collection in Pregnancy Safety Studies: Towards Standardisation of Data Elements in Pregnancy Reports from Public and Private Partners, A Contribution from the ConcePTION Project
Favre G, Richardson J, Moore A, Geissbuhler Y, Jehl V, Oliver A, et al.
Drug Saf . 2023 Dec; 47(3):227-236. PMID: 38114757
Introduction And Objective: The ConcePTION project aims to improve the way medication use during pregnancy is studied. This includes exploring the possibility of developing a distributed data processing and analysis...
6.
Neurodevelopment of babies born to mothers with epilepsy: A prospective observational cohort study
Bromley R, Bullen P, Campbell E, Craig J, Ingham A, Irwin B, et al.
Epilepsia . 2023 Jul; 64(9):2454-2471. PMID: 37403560
Objective: Despite widespread monotherapy use of lamotrigine or levetiracetam during pregnancy, prospectively collected, blinded child development data are still limited. The NaME (Neurodevelopment of Babies Born to Mothers With Epilepsy)...
7.
Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project
Richardson J, Moore A, Bromley R, Stellfeld M, Geissbuhler Y, Bluett-Duncan M, et al.
Drug Saf . 2023 Mar; 46(5):479-491. PMID: 36976447
Introduction And Objective: The risks and benefits of medication use in pregnancy are typically established through post-marketing observational studies. As there is currently no standardised or systematic approach to the...
8.
Maternal characteristics and pregnancy outcomes of hospitalized pregnant women with SARS-CoV-2 infection in South Africa: An International Network of Obstetric Survey Systems-based cohort study
Budhram S, Vannevel V, Botha T, Chauke L, Bhoora S, Balie G, et al.
Int J Gynaecol Obstet . 2021 Sep; 155(3):455-465. PMID: 34499750
Objective: To describe risk factors and outcomes of pregnant women infected with SARS-CoV-2 admitted to South African healthcare facilities. Methods: A population-based cohort study was conducted utilizing an amended International...
9.
Nine newly identified individuals refine the phenotype associated with MYT1L mutations
Windheuser I, Becker J, Cremer K, Hundertmark H, Yates L, Mangold E, et al.
Am J Med Genet A . 2020 Feb; 182(5):1021-1031. PMID: 32065501
Both point mutations and deletions of the MYT1L gene as well as microdeletions of chromosome band 2p25.3 including MYT1L are associated with intellectual disability, obesity, and behavioral problems. Thus, MYT1L...
10.
British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017
McAllister-Williams R, Baldwin D, Cantwell R, Easter A, Gilvarry E, Glover V, et al.
J Psychopharmacol . 2017 Apr; 31(5):519-552. PMID: 28440103
Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, owing to the uncertainties around risks of the illness...